NIH-funded research R01 grant

Understanding Post-Treatment Lyme Disease: What Predicts PTLD and How to Identify At-Risk Patients

Official title: Determinants of Post-Treatment Phenotypes in Lyme Disease

Funded at Johns Hopkins University · NIH-11360571 · Data updated 2026-11-12

This NIH grant looks at why some people recover after Lyme treatment while others develop lingering symptoms, and aims to create a clinical score to identify those at higher risk.

More Lyme Disease research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionJohns Hopkins University
NIH-funded
Lab location1 site (Baltimore, United States)
Project startJuly 1, 2023
Project endJune 30, 2028
Funding year2026
Award (this year)$608,082
NIH project number5R01AI178726-04
Project IDNIH-11360571 on NIH RePORTER

Who could benefit from this research

Could help

People who have or have had Lyme disease, especially those experiencing lingering symptoms after standard antibiotic treatment.

Less likely to help

People who fully recover after Lyme treatment or those with Lyme but no PTLD symptoms may not directly benefit from the risk-prediction tools.

What this research studies

If you’ve been treated for Lyme disease but still have symptoms afterward, this project aims to uncover the clinical and biological factors that distinguish those who recover from those who develop PTLD. The researchers will study groups of people with PTLD, healthy individuals, and people with early Lyme disease followed for a year after treatment, using advanced statistical and laboratory methods. The goal is to translate findings into practical tools that clinicians can use to predict PTLD risk and guide care. They will also look for new autoantibodies that may be linked to PTLD to better understand the disease process.

Why it matters

Potential benefit: If successful, the study could help doctors predict PTLD risk and tailor follow-up care to prevent or mitigate long-term symptoms.

How similar studies have gone: Previous work suggests variability in immune and metabolic factors may influence PTLD, but a comprehensive predictive model and validation are still needed.

Where this research is happening

  • Johns Hopkins University
    Baltimore, United States
    Active

Researchers

  • Principal investigator: Aucott, John — Johns Hopkins University
  • Study coordinator: Aucott, John

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.